Cargando…

Effect of the TERT mutation on the prognosis of patients with urothelial carcinoma: a systematic review and meta-analysis

BACKGROUND: Telomerase reverse transcriptase (TERT) mutation represents the most prevalent genetic mutation found in urothelial carcinoma (UC) and holds potential as a prognostic indicator for tumor outcomes. However, the association between TERT mutation and prognosis in UC patients remains poorly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shuai, Hui, Duan, Xi, Zhou, Jun-Jie, Liu, Yuan, Wu, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621162/ https://www.ncbi.nlm.nih.gov/pubmed/37915019 http://dx.doi.org/10.1186/s12894-023-01349-9

Ejemplares similares

Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma
por: Hayashi, Yujiro, et al.
Publicado: (2021)

TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas
por: Wang, Kun, et al.
Publicado: (2014)

TERT promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance
por: Liu, Tiantian, et al.
Publicado: (2023)

The Impact of Diabetes on the Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Systematic Review and Meta-Analysis
por: Gao, Xiaoshuai, et al.
Publicado: (2021)

Regulatory region mutations of TERT, PLEKHS1 and GPR126 genes as urinary biomarkers in upper tract urothelial carcinomas
por: Xing, Xiangling, et al.
Publicado: (2021)

TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor
por: de Kouchkovsky, Ivan, et al.
Publicado: (2021)

The role of telomerase reverse transcriptase (TERT) promoter mutations in prognosis in bladder cancer
por: Wan, Song, et al.
Publicado: (2021)

Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer
por: Avogbe, Patrice Hodonou, et al.
Publicado: (2019)

Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma: a systematic review and meta-analysis
por: Yang, Jing, et al.
Publicado: (2019)

Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell‐free DNA in upper tract urothelial carcinoma
por: Hayashi, Yujiro, et al.
Publicado: (2019)

Risk Factors for TERT Promoter Mutations with Papillary Thyroid Carcinoma Patients: A Meta-Analysis and Systematic Review
por: Mao, Jingxin, et al.
Publicado: (2022)

Do histological variants in urothelial carcinoma of the bladder portend poor prognosis? A systematic review and meta-analysis
por: Chen, Qingke, et al.
Publicado: (2017)

TERT promoter Mutation and Its Association with Clinicopathological Features and Prognosis of Papillary Thyroid Cancer: A Meta-analysis
por: Liu, Chunping, et al.
Publicado: (2016)

TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR
por: Wang, Kun, et al.
Publicado: (2014)

Trends of incidence and prognosis of upper tract urothelial carcinoma
por: Wu, Jianping, et al.
Publicado: (2021)

Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis
por: Kim, Hyung Suk, et al.
Publicado: (2016)

A Novel Methylation Marker NRN1 plus TERT and FGFR3 Mutation Using Urine Sediment Enables the Detection of Urothelial Bladder Carcinoma
por: Zhang, Junjie, et al.
Publicado: (2023)

TERT promoter mutations and gene amplification: Promoting TERT expression in Merkel cell carcinoma
por: Xie, Hong, et al.
Publicado: (2014)

Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the TERT 228 G>A/T Mutation
por: Russo, Ilaria J., et al.
Publicado: (2018)

SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma
por: Ma, Li-Jung, et al.
Publicado: (2016)

Combination Biomarker of Immune Checkpoints Predict Prognosis of Urothelial Carcinoma
por: Tsai, Chung-Ying, et al.
Publicado: (2021)

Impact of neoadjuvant chemotherapy on survival prognosis and pathological downstaging in patients presenting with high-risk upper tract urothelial carcinoma: A protocol for systematic review and meta analysis
por: Li, Kun, et al.
Publicado: (2020)

The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma
por: Yuan, Xiaotian, et al.
Publicado: (2017)

Adjuvant Radiotherapy for Upper Tract Urothelial Carcinoma: Systematic Review and Meta-Analysis
por: Zalay, Osbert, et al.
Publicado: (2022)

5α-reductase inhibitors impact prognosis of urothelial carcinoma
por: Wang, Chien-Sheng, et al.
Publicado: (2020)

TERT promoter mutations and monoallelic activation of TERT in cancer
por: Huang, F W, et al.
Publicado: (2015)

Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis
por: Yuan, Ping, et al.
Publicado: (2016)

The impact of tumor location and multifocality on prognosis for patients with upper tract urothelial carcinoma: a meta-analysis
por: Wu, YunJian, et al.
Publicado: (2014)

BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients
por: Sun, Jian, et al.
Publicado: (2016)

CSF-1 Overexpression Predicts Poor Prognosis in Upper Tract Urothelial Carcinomas
por: Hsu, Wei-Chi, et al.
Publicado: (2019)

TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma
por: Paulsson, Johan O., et al.
Publicado: (2018)

The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer
por: Jin, Anqi, et al.
Publicado: (2018)

MCM10 overexpression implicates adverse prognosis in urothelial carcinoma
por: Li, Wei-Ming, et al.
Publicado: (2016)

Prognostic value of pretreatment serum albumin−globulin ratio in urothelial carcinoma: A systematic review and meta-analysis
por: Xia, Zhongyou, et al.
Publicado: (2022)

Editorial: Urothelial carcinoma of renal pelvis and ureter, prognosis and recent advances
por: Wu, Shu-Yu, et al.
Publicado: (2023)

The prognostic value of tumor architecture in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: A systematic review and meta-analysis
por: Zhao, Hu, et al.
Publicado: (2020)

Association between rs2853669 in TERT gene and the risk and prognosis of human cancer: a systematic review and meta-analysis
por: Shen, Na, et al.
Publicado: (2017)

HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese Population
por: Zhou, Li, et al.
Publicado: (2023)

TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region
por: Pakmanesh, Hamid, et al.
Publicado: (2022)

The prognostic significance of hTERT overexpression in cancers: A systematic review and meta-analysis
por: Wang, Kai, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bms92orp6fgsomgev38pni776q